/Investor DB

YF Capital — 2021 Investments

2 investments dated 2021 · listed companies and verified rows first · show all

Accutar Biotechaccutarbio.cominApr 2021

Accutar Biotech applies artificial intelligence to drug discovery, using a hybrid approach of computational drug design followed by wet lab validation to reduce the time and cost of developing new drugs.

AI & Machine LearningBiotechDeep TechNew York, US

Jie Fan(Founder)inWei He(Executive Officer)Yimin Qian(Executive Officer)Xiangyan Sun(Executive Officer)Quan Zhou(Director)Long Zhu(Director)

Co-investors5Y CapitalCoatue ManagementIDG CapitalZhenFund

Dtyunxidtyunxi.comOct 2021 · $100M

Provider of enterprise-grade AI-native multi-agent solutions that deliver an "AI operations team" capable of autonomously driving business growth.

AI & Machine LearningEnterprise SoftwareSaaS

Galy Lee(Founder)

Co-investorsXiang He Capital

Rows marked “SEC filing” are inferred from directors named on the company's SEC Form D — public regulatory data, not a portfolio list published by the firm.